Li Q - Search Results

1

In situ recruitment of antigen-presenting cells by intratumoral GM-CSF gene delivery.

Pan PY, Li Y, Li Q, Gu P, Martinet O, Thung S, Chen SH. Pan PY, et al. Among authors: li y, li q. Cancer Immunol Immunother. 2004 Jan;53(1):17-25. doi: 10.1007/s00262-003-0417-4. Epub 2003 Sep 2. Cancer Immunol Immunother. 2004. PMID: 12955480 Free PMC article.

2

Role of immature myeloid Gr-1+ cells in the development of antitumor immunity.

Li Q, Pan PY, Gu P, Xu D, Chen SH. Li Q, et al. Cancer Res. 2004 Feb 1;64(3):1130-9. doi: 10.1158/0008-5472.can-03-1715. Cancer Res. 2004. PMID: 14871848

3

NK and CD8+ T cell-mediated eradication of poorly immunogenic B16-F10 melanoma by the combined action of IL-12 gene therapy and 4-1BB costimulation.

Xu D, Gu P, Pan PY, Li Q, Sato AI, Chen SH. Xu D, et al. Among authors: li q. Int J Cancer. 2004 Apr 20;109(4):499-506. doi: 10.1002/ijc.11696. Int J Cancer. 2004. PMID: 14991570

4

Regulation of dendritic cell function by NK cells: mechanisms underlying the synergism in the combination therapy of IL-12 and 4-1BB activation.

Pan PY, Gu P, Li Q, Xu D, Weber K, Chen SH. Pan PY, et al. Among authors: li q. J Immunol. 2004 Apr 15;172(8):4779-89. doi: 10.4049/jimmunol.172.8.4779. J Immunol. 2004. PMID: 15067054

5

Gr-1+CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host.

Huang B, Pan PY, Li Q, Sato AI, Levy DE, Bromberg J, Divino CM, Chen SH. Huang B, et al. Among authors: li q. Cancer Res. 2006 Jan 15;66(2):1123-31. doi: 10.1158/0008-5472.CAN-05-1299. Cancer Res. 2006. PMID: 16424049

6

Anti-PD-1 antibody-mediated activation of type 17 T-cells undermines checkpoint blockade therapy.

Li Q, Ngo PT, Egilmez NK. Li Q, et al. Cancer Immunol Immunother. 2021 Jun;70(6):1789-1796. doi: 10.1007/s00262-020-02795-2. Epub 2020 Nov 27. Cancer Immunol Immunother. 2021. PMID: 33245376 Free PMC article.

7

IL-21 enhances and sustains CD8+ T cell responses to achieve durable tumor immunity: comparative evaluation of IL-2, IL-15, and IL-21.

Moroz A, Eppolito C, Li Q, Tao J, Clegg CH, Shrikant PA. Moroz A, et al. Among authors: li q. J Immunol. 2004 Jul 15;173(2):900-9. doi: 10.4049/jimmunol.173.2.900. J Immunol. 2004. PMID: 15240677

8

A unique form of haptoglobin produced by murine hematopoietic cells supports B-cell survival, differentiation and immune response.

Huntoon KM, Russell L, Tracy E, Barbour KW, Li Q, Shrikant PA, Berger FG, Garrett-Sinha LA, Baumann H. Huntoon KM, et al. Among authors: li q. Mol Immunol. 2013 Oct;55(3-4):345-54. doi: 10.1016/j.molimm.2013.03.008. Epub 2013 Mar 30. Mol Immunol. 2013. PMID: 23548836 Free PMC article.

9

Tolerogenic Phenotype of IFN-γ-Induced IDO+ Dendritic Cells Is Maintained via an Autocrine IDO-Kynurenine/AhR-IDO Loop.

Li Q, Harden JL, Anderson CD, Egilmez NK. Li Q, et al. J Immunol. 2016 Aug 1;197(3):962-70. doi: 10.4049/jimmunol.1502615. Epub 2016 Jun 17. J Immunol. 2016. PMID: 27316681

10

Regulatory Rebound in IL-12-Treated Tumors Is Driven by Uncommitted Peripheral Regulatory T Cells.

Li Q, Virtuoso LP, Anderson CD, Egilmez NK. Li Q, et al. J Immunol. 2015 Aug 1;195(3):1293-300. doi: 10.4049/jimmunol.1403078. Epub 2015 Jun 17. J Immunol. 2015. PMID: 26085681

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

64,926 results

Search Page

Filters